A detailed history of Fox Run Management, L.L.C. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 5,894 shares of MRK stock, worth $577,906. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,894
Previous 16,169 63.55%
Holding current value
$577,906
Previous $2 Million 66.57%
% of portfolio
0.15%
Previous 0.39%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $1.14 Million - $1.33 Million
-10,275 Reduced 63.55%
5,894 $669,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $1.63 Million - $1.75 Million
13,164 Added 438.07%
16,169 $2 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $332,132 - $387,009
-2,933 Reduced 49.39%
3,005 $396,000
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $594,868 - $647,360
5,938 New
5,938 $647,000
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $350,642 - $393,048
-4,770 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$72.28 - $90.54 $344,775 - $431,875
4,770 New
4,770 $366,000
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $219,318 - $247,475
-2,827 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$76.08 - $82.93 $8,977 - $9,785
118 Added 4.36%
2,827 $238,000
Q2 2019

Jul 17, 2019

BUY
$69.84 - $81.59 $189,196 - $221,027
2,709 New
2,709 $227,000
Q1 2019

Oct 17, 2019

SELL
$69.58 - $79.36 $311,370 - $355,136
-4,475 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$65.24 - $75.71 $231,145 - $268,240
-3,543 Reduced 44.19%
4,475 $342,000
Q3 2018

Oct 05, 2018

BUY
$57.69 - $67.84 $130,552 - $153,521
2,263 Added 39.32%
8,018 $569,000
Q2 2018

Jul 17, 2018

BUY
$50.83 - $59.72 $292,526 - $343,688
5,755 New
5,755 $349,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.